These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37149351)

  • 1. Treatment-Resistant Late-Life Depression: A Review of Clinical Features, Neuropsychology, Neurobiology, and Treatment.
    Subramanian S; Oughli HA; Gebara MA; Palanca BJA; Lenze EJ
    Psychiatr Clin North Am; 2023 Jun; 46(2):371-389. PubMed ID: 37149351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated Intermittent Theta-Burst Stimulation for Treatment of Therapy-Resistant Depression in a Patient With Epilepsy and Implanted Vagus Nerve Stimulator: A Case Report.
    Abdelnaim MA; Schecklmann M; Lang-Hambauer V; Hebel T; Weber F; Langguth B
    J ECT; 2023 Sep; 39(3):e12-e13. PubMed ID: 37310081
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial.
    Kaster TS; Daskalakis ZJ; Noda Y; Knyahnytska Y; Downar J; Rajji TK; Levkovitz Y; Zangen A; Butters MA; Mulsant BH; Blumberger DM
    Neuropsychopharmacology; 2018 Oct; 43(11):2231-2238. PubMed ID: 29946106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.
    Aaronson ST; Sears P; Ruvuna F; Bunker M; Conway CR; Dougherty DD; Reimherr FW; Schwartz TL; Zajecka JM
    Am J Psychiatry; 2017 Jul; 174(7):640-648. PubMed ID: 28359201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment resistant late-life depression: A narrative review of psychosocial risk factors, non-pharmacological interventions, and the role of clinical phenotyping.
    Patrick RE; Dickinson RA; Gentry MT; Kim JU; Oberlin LE; Park S; Principe JL; Teixeira AL; Weisenbach SL
    J Affect Disord; 2024 Jul; 356():145-154. PubMed ID: 38593940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral S-ketamine effective after deep brain stimulation in severe treatment-resistant depression and extensive comorbidities.
    Veraart JKE; Kamphuis J; Schlegel M; Schoevers RA
    BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33495180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of late life depressive symptoms on the trajectories of insomnia symptoms during antidepressant treatment.
    Gebara MA; Kasckow J; Smagula SF; DiNapoli EA; Karp JF; Lenze EJ; Mulsant BH; Reynolds CF
    J Psychiatr Res; 2018 Jan; 96():162-166. PubMed ID: 29069615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review.
    Moreines JL; McClintock SM; Holtzheimer PE
    Brain Stimul; 2011 Jan; 4(1):17-27. PubMed ID: 21255751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms and observations: differences in time course during electroconvulsive therapy in geriatric depressed patients.
    Mahgoub N; Lerner M; Kalayam B; Young RC
    J ECT; 2014 Mar; 30(1):e7-8. PubMed ID: 24487646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study.
    Sonmez AI; Kucuker MU; Lewis CP; Kolla BP; Doruk Camsari D; Vande Voort JL; Schak KM; Kung S; Croarkin PE
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109763. PubMed ID: 31634515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ketamine's antidepressant effect: literature review on clinical use].
    De Maricourt P; Jay T; Goncalvès P; Lôo H; Gaillard R
    Encephale; 2014 Feb; 40(1):15-23. PubMed ID: 24434008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Usefulness of Therapeutic Neuromodulation for Major Depression: A Systematic Meta-Review of Recent Meta-Analyses.
    McGirr A; Berlim MT
    Psychiatr Clin North Am; 2018 Sep; 41(3):485-503. PubMed ID: 30098660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in brain stimulation for depression.
    Wani A; Trevino K; Marnell P; Husain MM
    Ann Clin Psychiatry; 2013 Aug; 25(3):217-24. PubMed ID: 23926577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "What else can we do?"-Provider perspectives on treatment-resistant depression in late life.
    Hamm ME; Karp JF; Lenard E; Dawdani A; Lavretsky H; Lenze EJ; Mulsant BH; Reynolds CF; Roose SP; Brown PJ
    J Am Geriatr Soc; 2022 Apr; 70(4):1190-1197. PubMed ID: 34862593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine plus propofol-electroconvulsive therapy (ECT) transiently improves the antidepressant effects and the associated brain functional alterations in patients with propofol-ECT-resistant depression.
    Zhang J; Tian H; Li J; Ji S; Chen S; Zhu J; Jiang D; Wang L; Li G; Chen M; Wang W; Lin X; Zhuo C
    Psychiatry Res; 2020 May; 287():112907. PubMed ID: 32179210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.
    Murrough JW; Burdick KE; Levitch CF; Perez AM; Brallier JW; Chang LC; Foulkes A; Charney DS; Mathew SJ; Iosifescu DV
    Neuropsychopharmacology; 2015 Mar; 40(5):1084-90. PubMed ID: 25374095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Ketamine in Elderly Patients with Treatment-Resistant Depression.
    Medeiros da Frota Ribeiro C; Riva-Posse P
    Curr Psychiatry Rep; 2017 Nov; 19(12):107. PubMed ID: 29138992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant late-life depression.
    Trevizol AP; Goldberger KW; Mulsant BH; Rajji TK; Downar J; Daskalakis ZJ; Blumberger DM
    Int J Geriatr Psychiatry; 2019 Jun; 34(6):822-827. PubMed ID: 30854751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.